Quality of Life and Antiretroviral Therapy Adherence: A Cross-Sectional Study in Colombia

AIDS Res Hum Retroviruses. 2022 Aug;38(8):660-669. doi: 10.1089/AID.2021.0233. Epub 2022 May 24.

Abstract

The introduction of highly active combined antiretroviral therapy (cART) has changed the management of HIV/AIDS, which is recognized as a chronic disease with relevant aspects, such as adherence and quality of life. This study aimed to compare clinical and demographic characteristics and health-related quality of life in people with adherence and non-adherence to cART. A cross-sectional study was carried out with 200 participants. The instruments used were the Adherence Follow-up Questionnaire, the Beck Depression Inventory-II, the 36-Item Short Form Health Survey and the WHOQOL-HIV BREF. Poisson regression was applied to obtain estimates of adjusted prevalence ratios (PRadj). Individuals lacking therapeutic support were more likely to be non-adherent than those with proper support (PR: 1.79). The health-related quality of life of individuals with non-adherence was 4% lower (PR = 0.96) in the general health domain than individuals with adherence. Non-adherence to cART was associated with lower quality of life in the general health domain and no therapeutic support.

Keywords: HIV clinical outcomes research; HIV therapies; epidemiology.

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • Colombia / epidemiology
  • Cross-Sectional Studies
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • Humans
  • Medication Adherence
  • Quality of Life*
  • Surveys and Questionnaires